219 related articles for article (PubMed ID: 36158487)
1. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
[TBL] [Abstract][Full Text] [Related]
2. Proteomics-based identification of proteins in tumor-derived exosomes as candidate biomarkers for colorectal cancer.
Zhou GY; Zhao DY; Yin TF; Wang QQ; Zhou YC; Yao SK
World J Gastrointest Oncol; 2023 Jul; 15(7):1227-1240. PubMed ID: 37546562
[TBL] [Abstract][Full Text] [Related]
3. Age-stratified proteomic characteristics and identification of promising precise clinical treatment targets of colorectal cancer.
Wang Q; Zhou Y; Zhou G; Qin G; Tan C; Yin T; Zhao D; Yao S
J Proteomics; 2023 Apr; 277():104863. PubMed ID: 36870673
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis.
Zou X; Feng B; Dong T; Yan G; Tan B; Shen H; Huang A; Zhang X; Zhang M; Yang P; Zheng M; Zhang Y
J Proteomics; 2013 Dec; 94():473-85. PubMed ID: 24332065
[TBL] [Abstract][Full Text] [Related]
5. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract][Full Text] [Related]
6. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic model based on urea cycle-related gene signature for colorectal cancer.
Guo H; Wang Y; Gou L; Wang X; Tang Y; Wang X
Front Surg; 2022; 9():1027655. PubMed ID: 36338624
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
[TBL] [Abstract][Full Text] [Related]
9. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
Yang G; Zhang Y; Yang J
Front Oncol; 2019; 9():1207. PubMed ID: 31799184
[TBL] [Abstract][Full Text] [Related]
10. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
11. An application of the 2-nitrobenzenesulfenyl method to proteomic profiling of human colorectal carcinoma: A novel approach for biomarker discovery.
Watanabe M; Takemasa I; Kawaguchi N; Miyake M; Nishimura N; Matsubara T; Matsuo E; Sekimoto M; Nagai K; Matsuura N; Monden M; Nishimura O
Proteomics Clin Appl; 2008 Jun; 2(6):925-35. PubMed ID: 21136890
[TBL] [Abstract][Full Text] [Related]
12. Integrated proteomic and phosphoproteomic analysis for characterization of colorectal cancer.
Zhu H; Li Y; Guo J; Feng S; Ge H; Gu C; Wang M; Nie R; Li N; Wang Y; Wang H; Zhong J; Qian X; He G
J Proteomics; 2023 Mar; 274():104808. PubMed ID: 36596410
[TBL] [Abstract][Full Text] [Related]
13. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer.
Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ
Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a 7-microRNA prognostic signature and identification of hub target genes in colorectal carcinoma.
Jiang S; Xie X; Jiang H
Transl Cancer Res; 2022 Feb; 11(2):367-381. PubMed ID: 35281422
[TBL] [Abstract][Full Text] [Related]
16. TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
Jing L; Feng L; Zhou Z; Shi S; Deng R; Wang Z; Zhang Y; Ren Z; Liu Y
Oncol Rep; 2020 Aug; 44(2):628-636. PubMed ID: 32627044
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
18. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
19. RNA Binding Protein-Based Model for Prognostic Prediction of Colorectal Cancer.
Li T; Hui W; Halike H; Gao F
Technol Cancer Res Treat; 2021; 20():15330338211019504. PubMed ID: 34080453
[TBL] [Abstract][Full Text] [Related]
20. Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer.
Yin TF; Du SY; Zhao DY; Sun XZ; Zhou YC; Wang QQ; Zhou GY; Yao SK
World J Clin Cases; 2022 Apr; 10(11):3352-3368. PubMed ID: 35611198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]